145 related articles for article (PubMed ID: 19364364)
21. Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).
Beran RG; Spira PJ
Cephalalgia; 2011 Apr; 31(5):530-6. PubMed ID: 21059626
[TBL] [Abstract][Full Text] [Related]
22. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
23. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Solaro C; de Sire A; Messmer Uccelli M; Mueller M; Bergamaschi R; Gasperini C; Restivo DA; Stabile MR; Patti F
Eur J Neurol; 2020 Nov; 27(11):2209-2216. PubMed ID: 32558044
[TBL] [Abstract][Full Text] [Related]
26. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy.
Hagemann A; May TW; Nieder E; Witte-Bölt K; Pohlmann-Eden B; Elger CE; Tergau F; Schulze-Bonhage A; Straub HB; Arnold S; Brandt C
Epilepsy Res; 2013 Mar; 104(1-2):140-50. PubMed ID: 22959715
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis.
Vollmer TL; Robinson MJ; Risser RC; Malcolm SK
Pain Pract; 2014 Nov; 14(8):732-44. PubMed ID: 24152240
[TBL] [Abstract][Full Text] [Related]
28. Effect of levetiracetam on depression and anxiety in adult epileptic patients.
Mazza M; Martini A; Scoppetta M; Mazza S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):539-43. PubMed ID: 18031881
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
[TBL] [Abstract][Full Text] [Related]
30. A prospective pilot study of levetiracetam for body dysmorphic disorder.
Phillips KA; Menard W
CNS Spectr; 2009 May; 14(5):252-60. PubMed ID: 19407724
[TBL] [Abstract][Full Text] [Related]
31. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study.
Ostenfeld T; Krishen A; Lai RY; Bullman J; Baines AJ; Green J; Anand P; Kelly M
Eur J Pain; 2013 Jul; 17(6):844-57. PubMed ID: 23239139
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
33. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
[TBL] [Abstract][Full Text] [Related]
35. The Role of Levetiracetam in Treating Chronic Neuropathic Pain Symptoms.
Crawford-Faucher A; Huijon RM
Am Fam Physician; 2015 Jul; 92(1):23-4. PubMed ID: 26132123
[No Abstract] [Full Text] [Related]
36. Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy.
Ozcan M; Ayar A; Canpolat S; Kutlu S
Acta Anaesthesiol Scand; 2008 Aug; 52(7):926-30. PubMed ID: 18477089
[TBL] [Abstract][Full Text] [Related]
37. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
[TBL] [Abstract][Full Text] [Related]
38. [The effectiveness of levetiracetam in the treatment of neuropathic pain].
Del Pozo E; Pereira-Pérez E; González-Contreras LG
Rev Neurol; 2011 Jul; 53(2):65-72. PubMed ID: 21720975
[TBL] [Abstract][Full Text] [Related]
39. Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India.
Verma A; Srivastava D; Kumar A; Singh V
Clin Neuropharmacol; 2013; 36(6):193-7. PubMed ID: 24201237
[TBL] [Abstract][Full Text] [Related]
40. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.
Mula M; Sander JW; Trimble MR
Seizure; 2006 Sep; 15(6):405-8. PubMed ID: 16809055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
